Vertical: CNMBase Year: 2025
Market Size (2025)
$58.02M
Projected (2032)
$91.48M
CAGR (2022–2032)
6.8%
Key Players
9+
Market Overview
The Global Diamide Insecticide Intermediates Market was valued at USD 58.023 Million in 2025 and is projected to reach USD 91.485 Million by 2032, expanding at a CAGR of 6.71% over 2026–2032. Between 2025 and 2032 the market is expected to add USD 33.462 Million in absolute value. The market grew from USD 47.557 Million in 2022 to USD 54.313 Million in 2024, reflecting the steady expansion of anthranilic diamide technical manufacturing as patents protecting chlorantraniliprole and cyantraniliprole lapsed across major markets.
Diamide insecticide intermediates are the key chemical building blocks, principally the substituted pyrazole carboxylic acid (commonly referred to in the trade as "K-acid"), the substituted anthranilamides ("K-amine" and its cyano analogue) and the chloropyridine precursors, from which technical-grade chlorantraniliprole, cyantraniliprole and related diamide active ingredients are synthesised. Demand is therefore directly linked to diamide technical production volumes, which have risen sharply in China and India since the expiry of the chlorantraniliprole compound patent in China in August 2022. At the same time, a large wave of capacity additions has compressed technical and intermediate prices, so value growth is more moderate than volume growth.
Key Findings
By Downstream Product: Chlorantraniliprole is the largest segment with a 70.0% share in 2025 (USD 40.616 Million), while Cyantraniliprole & Others is the fastest-growing segment at a CAGR of 8.36% over 2026–2032.
By Purity: 98% & Above dominates with a 85.0% share in 2025 (USD 49.320 Million) and is also the fastest-growing purity grade, at a CAGR of 7.14%.
By Region: Asia Pacific is the leading region, accounting for 78.0% of global value in 2025 (USD 45.258 Million). Middle East & Africa is the fastest-growing region, with a CAGR of 8.55%.
By Country: China is the leading country, with USD 25.344 Million in 2025, equivalent to 43.7% of the global market. UAE (Middle East & Africa) is the fastest-growing country, at a CAGR of 10.05%.
India is the second-largest country market at USD 13.577 Million in 2025 and is growing at a CAGR of 8.45%, well above the global average, supported by domestic technical production and import substitution.
Segmentation Summary
The market is analysed by Downstream Product (Chlorantraniliprole and Cyantraniliprole & Others), by Purity (98% & Above and Below 98%) and by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa), with country-level coverage in each region. Chlorantraniliprole intermediates account for the bulk of demand because chlorantraniliprole is the most widely used diamide active ingredient worldwide. Cyantraniliprole & Others is gaining share, rising from 30.0% in 2025 to 33.5% in 2032, as generic cyantraniliprole production expands following the expiry of key intermediate patents. Intermediates with purity of 98% & Above represent the large majority of value, because technical producers seeking registrations in regulated markets require tightly controlled impurity profiles.
Competitive Landscape Summary
The competitive landscape combines the originator of the diamide class, FMC Corporation, with a rapidly expanding group of Chinese and Indian manufacturers. FMC continues to supply branded Rynaxypyr (chlorantraniliprole) and Cyazypyr (cyantraniliprole) technicals through its own plants and contract manufacturing partners, while Chinese producers such as Nanjing Red Sun, Shandong Youdao Chemical, Lier Chemical and Zhejiang Zhongshan Chemical have built large integrated capacities spanning intermediates and technicals. In India, Natco Pharma, Heranba Industries, GSP Crop Science, UPL and ADAMA have established technical or backward-integrated positions. Competition is driven by cost, process integration, regulatory registrations and secure access to key intermediates.
Challenges and Opportunities
The main challenge is structural overcapacity in China, which pushed chlorantraniliprole technical prices down sharply in 2024 and led the China Pesticide Industry Association to urge producers in February 2026 not to sell below production cost. Process safety is a second challenge: nitration and bromination steps used in intermediate synthesis carry significant hazards, and serious incidents in 2025 have led to stricter oversight in China. Opportunities lie in cyantraniliprole and newer diamide intermediates, backward integration in India, contract manufacturing for multinational registrants, and fast-growing demand in Latin America and the Middle East & Africa.
Future Outlook
Over 2026–2032 the market is expected to grow at a CAGR of 6.71%, reaching USD 91.485 Million. With process patents for chlorantraniliprole having expired in many major markets in December 2025, generic technical production is expected to broaden further, supporting intermediate demand. Asia Pacific will remain the manufacturing centre of the industry, while value growth will increasingly be shaped by price discipline, consolidation of marginal capacity, investment in safer continuous processing and the shift towards higher-purity intermediates for regulated markets.
The Diamide Insecticide Intermediates Market market is projected to grow at a CAGR of 6.8% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Diamide insecticides are a class of insecticides that act on insect ryanodine receptors, classified by the Insecticide Resistance Action Committee (IRAC) as Group 28 ryanodine receptor modulators. They cause uncontrolled release of calcium from muscle cells, leading to rapid feeding cessation, paralysis and death, and are particularly effective against lepidopteran pests such as stem borers, fall armyworm, diamondback moth, bollworms and fruit borers. Chlorantraniliprole and cyantraniliprole are the leading anthranilic diamide active ingredients.
For the purposes of this study, diamide insecticide intermediates are the chemical compounds produced and traded for the synthesis of diamide technical active ingredients. The market includes:
Pyrazole carboxylic acid intermediates, chiefly 3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxylic acid, and their precursors such as 3-chloro-2-hydrazinopyridine.
Anthranilamide intermediates, chiefly 2-amino-5-chloro-N,3-dimethylbenzamide for chlorantraniliprole and 2-amino-5-cyano-N,3-dimethylbenzamide for cyantraniliprole.
Dedicated chloropyridine intermediates, such as 2,3-dichloropyridine, to the extent supplied for diamide synthesis.
Intermediates for other diamide active ingredients, which are grouped with cyantraniliprole under the Cyantraniliprole & Others segment.
The market excludes finished technical-grade active ingredients, formulated end-use products (suspension concentrates, granules, oil dispersions and mixtures), and basic commodity chemicals such as pyridine, methylamine, toluic acid derivatives and halogenating agents when they are sold for uses other than diamide intermediate synthesis. Market value is measured at the intermediate manufacturer's selling price.
Research Objectives
To estimate the size of the global diamide insecticide intermediates market in USD Million for the historic years 2022–2024 and the base year 2025, and to forecast it for 2026–2032.
To analyse the market by Downstream Product (Chlorantraniliprole; Cyantraniliprole & Others) and assess how the expiry of diamide patents is shifting demand between the two segments.
To analyse the market by Purity (98% & Above; Below 98%) and evaluate how registration and impurity-profile requirements influence the demand for high-purity intermediates.
To assess regional and country-level demand, with particular attention to the manufacturing hubs of China and India and the consuming markets of the Americas, Europe and the Middle East & Africa.
To identify the drivers, restraints, opportunities, trends and challenges affecting intermediate demand, including overcapacity, price movements and process-safety regulation.
To map the value chain from raw materials such as pyridine derivatives and toluic acid derivatives through intermediate synthesis to diamide technical producers.
To profile the competitive environment, including the originator, integrated Chinese producers and Indian technical manufacturers, and to track key developments from 2022 onward.
To review the regulatory frameworks governing pesticide active ingredients and chemical intermediates in major regions.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study followed a structured research process combining secondary research, primary research and analytical modelling. The process began with defining the market and its segmentation, followed by a review of the diamide value chain to identify the intermediates that are commercially traded and the producers involved. Market size was then estimated using complementary top-down and bottom-up approaches, validated through primary inputs from industry participants, and projected over the forecast period using a factor-based forecasting model.
Stage 1: Market definition, scope and segmentation framework.
Stage 2: Secondary research on technical production, capacities, trade flows, prices and regulations.
Stage 3: Primary research with supply-side and demand-side participants.
Stage 4: Market size estimation, data triangulation and validation.
Stage 5: Forecasting, scenario checks and report preparation.
Secondary Research
Secondary research covered sources that are specific to the agrochemical intermediates industry:
Industry associations: CropLife International and its regional bodies, the China Pesticide Industry Association, the Crop Care Federation of India, the Pesticides Manufacturers & Formulators Association of India and the Insecticide Resistance Action Committee.
Government and regulatory bodies: US Environmental Protection Agency, European Commission and European Food Safety Authority, India's Central Insecticides Board & Registration Committee, China's Institute for the Control of Agrochemicals (ICAMA), Brazil's Ministry of Agriculture and Livestock, and Australia's APVMA.
Company filings: annual reports, stock exchange filings, investor presentations and environmental impact assessment documents of originator, generic and intermediate manufacturers.
Trade journals and industry media: agrochemical trade publications, chemical industry news services and price-reporting sources covering technical and intermediate prices.
Paid and statistical databases: trade statistics (HS codes for heterocyclic compounds and insecticides), patent databases and company databases.
Primary Research
Primary research was used to validate the market structure, verify pricing and volume assumptions and gather qualitative insight on market dynamics. Discussions were held with participants across the value chain:
Supply side: intermediate manufacturers, diamide technical producers, contract manufacturing organisations, raw material suppliers and chemical traders.
Demand side: procurement and technical managers at technical and formulation companies, registration specialists and agrochemical distributors.
Industry experts: process chemists, regulatory consultants and agrochemical industry analysts.
The objectives of primary research were to confirm intermediate consumption per tonne of technical output, understand purity-grade preferences by end market, validate capacity utilisation and price trends, and identify emerging developments in capacity, regulation and technology.
Market Size Estimation
Top-down approach: The global diamide technical market was assessed by active ingredient, and the value attributable to intermediates was derived by applying intermediate consumption ratios and intermediate-to-technical price relationships. The resulting value was distributed across segments, regions and countries using production, trade and consumption data.
Bottom-up approach: Production and sales of intermediates were estimated for individual manufacturers and regions based on installed capacity, utilisation rates, captive consumption and merchant sales, and multiplied by prevailing average selling prices. Country-level estimates were aggregated to regional and global totals.
Data triangulation: Results from the two approaches were compared and reconciled with primary research inputs. Where differences arose, assumptions on utilisation, captive consumption and pricing were reviewed until the estimates converged within an acceptable range.
Forecasting Methodology
The forecast was developed using a factor-based model anchored on the 2025 base year. Factors considered include projected diamide technical demand by region, the timing of patent expiries, crop area and pest pressure trends, capacity additions and closures, expected price trajectories for technical and intermediates, shifts in purity requirements, and regulatory developments. Each factor was assessed for direction and magnitude of impact over the short, medium and long term (Section 4.2), and the forecasts were cross-checked against historic growth and industry expectations.
Assumptions and Limitations
Market values are expressed in nominal USD at average exchange rates for each year; currency fluctuations are not separately modelled.
Captive intermediate production consumed within integrated technical plants is valued at equivalent merchant prices.
Announced capacities in China are treated as potential supply rather than operating capacity unless commissioning is confirmed.
The forecast assumes no outright regulatory ban on chlorantraniliprole or cyantraniliprole in major markets during 2026–2032.
Prices of technical and intermediates are volatile; sharp changes due to capacity rationalisation or safety-driven shutdowns may cause actual values to differ from estimates.
Limited public disclosure by privately held Chinese producers constrains the precision of company-level estimates.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The global diamide insecticide intermediates market is moderately fragmented. At the leading edge, the originator FMC Corporation and a small group of large integrated Chinese producers control significant shares of technical output and the supply of critical intermediates such as 2,3-dichloropyridine and pyrazole acid. Beyond them, a long tail of Chinese and Indian producers has entered since the patent expiries of 2022–2025, many of them with announced capacities that exceed current demand.
Competition is primarily based on cost, which depends on the degree of backward integration, process efficiency and scale. Secondary competitive factors include intermediate purity and consistency, the ability to support registrations in regulated markets, process-safety and environmental compliance, and freedom to operate with respect to remaining process patents. The years 2022–2026 saw intense price competition, patent litigation in China, India, Australia and the United States, and capacity announcements followed by revisions, indicating an industry moving from rapid expansion toward rationalisation.
Key Player Positioning
Leaders: FMC Corporation, as originator of the anthranilic diamide class with the Rynaxypyr and Cyazypyr brands, a global manufacturing and contract-partner network and the broadest registration portfolio; Nanjing Red Sun, which reports a dominant global position in 2,3-dichloropyridine and a significant share of chlorantraniliprole technical through integrated pyridine chemistry; and Shandong Youdao Chemical, described as the largest chlorantraniliprole technical producer by capacity, with registrations in China, the United States and other markets.
Challengers: Lier Chemical, which has extended its chloropyridine platform into chlorantraniliprole at its Guang'an base; Zhejiang Zhongshan Chemical through its Inner Mongolia Zhonggao project; Natco Pharma, India's first chlorantraniliprole technical producer and an early cyantraniliprole entrant; UPL, which manufactures Rynaxypyr technical in India for FMC under a long-term arrangement; and ADAMA, which launched backward-integrated chlorantraniliprole offerings in India in 2023.
Niche players: Anhui Hengke Chemical, a specialist in pyrazole acid and anthranilamide intermediates moving into technical production; Heranba Industries, which received Indian approval for chlorantraniliprole technical in 2023; and GSP Crop Science, an early Indian generic producer that secured freedom to operate through litigation in 2022.
Competitor Dashboard
The dashboard below rates each profiled company on product portfolio, regional presence, strategic alliances and industry experience in the diamide intermediates and technicals value chain.
Threat of New Entrants: Medium
Patent expiry has lowered legal barriers and many new producers have entered since 2022.
Multi-step hazardous chemistry, process know-how and environmental and safety permits still require significant capital and expertise.
Overcapacity and low prices reduce the attractiveness of new entry.
Bargaining Power of Suppliers: Medium
Key raw materials such as 2,3-dichloropyridine are produced by a limited number of suppliers, with Nanjing Red Sun reporting a dominant global share.
Most other inputs are commodity chemicals available from multiple suppliers.
Integrated producers reduce supplier influence by producing precursors captively.
Bargaining Power of Buyers: High
Buyers are a relatively concentrated group of technical producers and registrants.
Abundant intermediate and technical capacity gives buyers strong price leverage.
Buyers can integrate backwards, as several Chinese and Indian producers have done.
Threat of Substitutes: Medium
Alternative insecticide classes, including spinosyns, avermectins such as emamectin benzoate, oxadiazines and newer modes of action, compete for lepidopteran control.
Diamides offer a distinctive mode of action, low use rates and a favourable safety profile, limiting substitution.
Resistance management encourages rotation with other modes of action, capping diamide share.
Competitive Rivalry: High
A large number of Chinese and Indian producers compete mainly on price.
Significant price declines in 2024 reflect intense rivalry.
Differentiation is limited to purity, consistency, registrations and integration.
Threat of New Entrants: Medium; Patent expiry has lowered legal barriers and many new producers have entered since 2022.
Bargaining Power of Suppliers: Medium; Key raw materials such as 2,3-dichloropyridine are produced by a limited number of suppliers, with Nanjing Red Sun reporting a dominant global share.
Bargaining Power of Buyers: High; Buyers are a relatively concentrated group of technical producers and registrants.
Threat of Substitutes: Medium; Alternative insecticide classes, including spinosyns, avermectins such as emamectin benzoate, oxadiazines and newer modes of action, compete for lepidopteran control.
Competitive Rivalry: High; A large number of Chinese and Indian producers compete mainly on price.
Market estimates by geography (2032)
InsightAsia Pacific leads with $71.59M by 2032, while Latin America is projected to grow fastest at a 8.6% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $3.12M | $3.86M | $4.99M | 4.8% | 5% |
| Europe | $4.11M | $5.16M | $6.72M | 5.0% | 7% |
| Asia Pacific | $36.74M | $51.69M | $71.59M | 6.9% | 78% |
| Latin America | $2.69M | $4.10M | $6.13M | 8.6% | 7% |
| Middle East & Africa | $0.90M | $1.36M | $2.06M | 8.6% | 2% |
| Total | $47.56M | $66.17M | $91.48M | 6.8% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$91.48M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Chlorantraniliprole | $60.84M | 5.9% | 66% |
| Cyantraniliprole & Others | $30.65M | 8.6% | 34% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Diamide Insecticide Intermediates Market covering market dynamics, competitive landscape, and strategic outlook.
The Diamide Insecticide Intermediates Market market is projected to reach $91.48M by 2032, growing at 6.8% CAGR. The Chlorantraniliprole segment holds the largest share.
The diamide insecticide intermediates market is shaped by the life cycle of the diamide class. The expiry of compound and process patents has opened the market to generic producers, triggering a surge in technical and intermediate capacity, especially in China and India. Demand is underpinned by the strong agronomic position of diamides against lepidopteran pests, while value growth is tempered by overcapacity, price erosion and tightening process-safety regulation. The factor analysis in Section 4.2 summarises these influences; the impact scores shown are analyst assessments on a scale of 1 to 10, where a higher score indicates a stronger impact on the market in the period indicated.
Patent Expiry Expanding Generic Diamide Technical Production
The single most important driver of intermediate demand is the expiry of the patents that protected chlorantraniliprole and cyantraniliprole. The chlorantraniliprole compound patent in China expired in August 2022, and FMC Corporation has stated in its annual filing for 2025 that composition-of-matter patents for Rynaxypyr and Cyazypyr have expired in all major markets, with process patents expiring in many major markets in December 2025, leading it to expect generic chlorantraniliprole in all markets in 2026. Each new generic technical producer requires a reliable supply of pyrazole acid and anthranilamide intermediates, either produced captively or purchased from merchant suppliers. In China, the number of valid chlorantraniliprole registrations has risen into the hundreds, and in India domestic manufacturers obtained technical registrations from 2021 onward. This broadening of the producer base has multiplied the number of buyers of intermediates and increased total volumes, and it is expected to continue to support demand as generic penetration extends into the Americas and Europe during the forecast period.
Strong Agronomic Demand for Lepidopteran Pest Control
Diamides are among the most widely used insecticides for controlling caterpillar pests in rice, maize, soybean, cotton, sugarcane, fruits and vegetables. Their selectivity, low application rates and favourable toxicological profile have made them a preferred option where older chemistries face resistance or regulatory restrictions. The spread of fall armyworm (Spodoptera frugiperda) from the Americas to Africa from 2016 and to South and Southeast Asia from 2018 created large new areas of demand, while rice stem borers in Asia and Helicoverpa and sugarcane borers in Brazil sustain high usage. Because diamides belong to a single mode-of-action group, resistance management programmes encourage their use in rotations and mixtures rather than replacing them, maintaining a stable demand base. This agronomic pull translates directly into technical demand and, in turn, demand for diamide intermediates.
Import Substitution and Backward Integration in India
India has become the second most important centre of diamide production after China. Domestic companies such as Natco Pharma, Heranba Industries and GSP Crop Science obtained technical registrations or launched chlorantraniliprole products between 2021 and 2023, and industry reporting indicates that India's imports of chlorantraniliprole technical fell from more than 1,100 tonnes in 2021 to very low levels by 2023 as local production started. Many Indian producers still import key intermediates, particularly pyrazole acid, from China, creating a strong incentive to integrate backwards into intermediate synthesis. Supply chain diversification by multinational crop protection companies, which seek alternatives to single-country sourcing, adds further support. These factors explain India's growth rate of 8.45% over 2026–2032, the highest among large country markets, and make India a key source of incremental intermediate demand and capacity.
Rising Requirement for High-Purity, Registration-Grade Intermediates
Regulators assess technical active ingredients on the basis of their impurity profile, and generic producers seeking registration in the United States, the European Union, Brazil or Australia must demonstrate equivalence with the reference specification. This places a premium on intermediates with high assay and low levels of relevant impurities, which reduce purification losses and improve technical yields. As Chinese producers increasingly pursue their own registrations in regulated markets, illustrated by Shandong Youdao Chemical's US EPA registration for chlorantraniliprole technical in April 2025, demand for high-purity intermediates is rising faster than for lower grades. This is reflected in the 98% & Above segment, which is projected to grow at a CAGR of 7.14%, compared with 4.01% for Below 98%.
Cyantraniliprole and Next-Generation Diamide Intermediates
Cyantraniliprole has a broader spectrum than chlorantraniliprole, including sucking pests such as whiteflies and thrips, and is used in seed treatment, soil and foliar applications. Generic production is at an earlier stage: Natco Pharma launched a cyantraniliprole 10.26% OD formulation in India in April 2025, and Anhui Hengke Chemical has announced plans for cyantraniliprole technical and its cyano intermediate. The Cyantraniliprole & Others segment is expected to grow at a CAGR of 8.36%, offering intermediate producers a higher-growth niche with less price competition than chlorantraniliprole.
Backward-Integrated and Contract Manufacturing Supply
Technical producers outside China, especially in India, seek secure, non-concentrated sources of pyrazole acid and anthranilamide intermediates. Companies able to offer integrated, compliant intermediate supply, or contract manufacturing for multinational registrants, can capture long-term supply agreements. FMC's own sourcing model, which relies on intermediates mainly from China and India and on cost-plus manufacturing partners, illustrates the scale of this opportunity.
High-Growth Demand in Latin America and the Middle East & Africa
Latin America and the Middle East & Africa are the fastest-growing regions, with CAGRs of 8.42% and 8.55% respectively over 2026–2032. Large soybean, maize, cotton and sugarcane areas in Brazil and Argentina, and the spread of fall armyworm and expanding protected agriculture in Africa and the Gulf, are driving diamide uptake. Intermediate and technical producers that secure registrations and distribution partnerships in these regions can benefit from growth well above the global average.
Overcapacity and Price Erosion
Capacity additions in China have far exceeded demand. Industry estimates indicate declared chlorantraniliprole technical capacity in China of more than 130,000 tonnes by early 2025, against global technical demand of the order of 13,000 tonnes. Reported technical prices in China fell from about CNY 310,000 per tonne to about CNY 200,000 per tonne during 2024. In February 2026, the China Pesticide Industry Association set an indicative average production cost of about CNY 233,000 per tonne and urged producers not to sell below cost. Lower technical prices pass through to intermediates, limiting value growth even when volumes rise, and squeezing the margins of non-integrated intermediate suppliers.
Process-Safety and Environmental Compliance Burden
The synthesis of diamide intermediates involves nitration, halogenation, bromination and hydrazine chemistry, all of which require stringent process-safety controls. An explosion at Shandong Youdao Chemical's plant on 27 May 2025 caused multiple fatalities and temporarily tightened chlorantraniliprole supply. In January 2026, China's emergency management authorities proposed listing 2-nitro-3-methylbenzoic acid, a precursor of the anthranilamide intermediate, as a hazardous chemical following several incidents at plants producing it. Stricter permitting, inspections and safety investments raise costs and can delay new capacity, particularly for smaller producers.
Patent Litigation and Registration Barriers
Although compound patents have expired, process and intermediate patents have been actively enforced. FMC obtained injunctions in China in 2022 relating to a key chlorantraniliprole intermediate and settled disputes with Imtrade in Australia (2024) and Albaugh in the United States (2024). In India, litigation over process and intermediate patents continued into late 2025. Together with the cost and time required for data packages and registrations in regulated markets, these barriers slow market entry outside Asia.
Shift to Continuous-Flow and Safer Processes
Producers are adopting continuous-flow reactors and process intensification for hazardous steps, reducing inventories of energetic intermediates and improving yield and consistency. Shandong Youdao Chemical, for example, describes its chlorantraniliprole production as based on a continuous-flow process. Regulatory pressure following safety incidents is expected to accelerate this trend.
Price Discipline and Capacity Rationalisation in China
After the steep price declines of 2024, the industry has moved toward price discipline, including association guidance on production costs in February 2026. Supply disruption after the May 2025 explosion and revised project scopes, such as the approval of a reduced 12,000 tonne per year chlorantraniliprole project for Inner Mongolia Zhonggao Chemical in May 2026, indicate that not all announced capacity will be built.
Repositioning by the Originator
FMC has responded to generic entry by focusing on advanced formulations and mixtures and by lowering diamide manufacturing costs. In February 2026 it began a review of strategic options, and in May 2026 it agreed to sell its India commercial business to Crystal Crop Protection for USD 252 Million, while continuing to supply diamides to the buyer. These moves reshape demand patterns for intermediates sourced by the originator and its partners.
Direct Registrations by Asian Producers in Regulated Markets
Chinese and Indian producers increasingly hold their own registrations in regulated markets rather than selling only through distributors. This raises the importance of documented, high-purity intermediate supply chains and creates a challenge for producers that lack the data packages, quality systems and traceability required by regulators.
The diamide intermediates value chain links commodity chemical producers with diamide technical manufacturers and, ultimately, growers. The main stages are described below.
Value capture is highest for producers that integrate from 2,3-dichloropyridine or the anthranilamide through to technical, as integration reduces exposure to merchant price swings and secures quality control. Non-integrated intermediate suppliers depend on a concentrated group of technical buyers and are more exposed to price competition.
North America
United States: pesticide active ingredients and products are registered by the EPA under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA); residue tolerances are set under the Federal Food, Drug, and Cosmetic Act (FFDCA). Chlorantraniliprole is subject to EPA registration review (docket EPA-HQ-OPP-2020-0034). Chemical intermediates not registered as pesticides fall under the Toxic Substances Control Act (TSCA).
Canada: pest control products are regulated by Health Canada's Pest Management Regulatory Agency (PMRA) under the Pest Control Products Act.
Mexico: pesticide registration involves COFEPRIS together with agriculture and environment authorities.
Europe
European Union: active substances are approved under Regulation (EC) No 1107/2009 and maximum residue levels are set under Regulation (EC) No 396/2005, with scientific assessment by EFSA. The approval of chlorantraniliprole was extended to 31 May 2027 by Commission Implementing Regulation (EU) 2024/2781.
Chemical intermediates: manufacture and import are subject to REACH (Regulation (EC) No 1907/2006) and classification and labelling under the CLP Regulation (EC) No 1272/2008; major chemical sites are subject to the Seveso III Directive (2012/18/EU).
United Kingdom: since leaving the EU, Great Britain operates its own pesticide approval and maximum residue level regime administered by the Health and Safety Executive.
Asia Pacific
India: pesticides are registered by the Central Insecticides Board & Registration Committee (CIB&RC) under the Insecticides Act, 1968 and the Insecticides Rules, 1971; new manufacturing units require environmental clearance under the Environment Impact Assessment Notification, 2006.
China: pesticide registration is administered by ICAMA under the Ministry of Agriculture and Rural Affairs pursuant to the Regulations on Pesticide Administration (revised 2017); hazardous chemical production is governed by the Regulations on the Safe Management of Hazardous Chemicals and work safety laws.
Japan: agricultural chemicals are registered under the Agricultural Chemicals Control Act, with information managed by MAFF and FAMIC.
Australia: agricultural chemicals are registered by the Australian Pesticides and Veterinary Medicines Authority (APVMA) under the Agvet Code.
Latin America
Brazil: pesticide registration is governed by Law No. 14,785/2023, which replaced Law No. 7,802/1989, with the Ministry of Agriculture and Livestock (MAPA) as the registering authority alongside ANVISA and IBAMA.
Argentina: plant protection products are registered by the National Agri-Food Health and Quality Service (SENASA).
Middle East & Africa
South Africa: agricultural remedies are registered under the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act 36 of 1947).
Gulf countries: pesticide registration is handled by national authorities such as the UAE Ministry of Climate Change and Environment and Saudi Arabia's Ministry of Environment, Water and Agriculture.
Apr 2022: FMC Corporation; Patent Litigation; Obtained a permanent injunction from a court in Hangzhou, China, against Udragon for infringement of a patent covering a key chlorantraniliprole intermediate.
May 2022: FMC Corporation; Patent Litigation; Obtained a pre-suit injunction from a court in Ningbo, China, against Zhejiang Yongtai Technology relating to chlorantraniliprole patents.
Sep 2022: Natco Pharma Ltd.; Product Launch; Launched NATGEN, a chlorantraniliprole 18.5% SC formulation, in India based on its own technical.
Oct 2022: Shandong Youdao Chemical Co., Ltd.; Registration; Received Chinese registration for chlorantraniliprole technical.
Nov 2022: GSP Crop Science Ltd.; Legal; Delhi High Court declined FMC's request for an interim injunction on a chlorantraniliprole process patent, allowing GSP to market its product.
Feb 2023: Nanjing Red Sun Co., Ltd.; Expansion; Subsidiary Chongqing Huage received environmental approval for a 2,000 tonne per year chlorantraniliprole project.
Apr 2023: Heranba Industries Ltd.; Approval; Received approval from India's CIB&RC for chlorantraniliprole technical under Section 9(4).
Aug 2023: Agrow Allied Ventures; Expansion; Began manufacturing chlorantraniliprole technical in India and reported registration of the product in the EU.
Sep 2023: ADAMA Ltd.; Product Launch; Launched chlorantraniliprole-based Cosayr and Lapidos in India, citing new in-house, backward-integrated production.
Jan 2024: Shandong Youdao Chemical Co., Ltd.; Expansion; Total chlorantraniliprole technical capacity reported at 11,000 tonnes per year after completion of phase II.
May 2024: FMC Corporation; Settlement; Settled a patent infringement dispute with Imtrade in Australia relating to imported chlorantraniliprole.
Aug 2024: Nanjing Red Sun Co., Ltd.; Registration; Obtained its own Chinese registration for 97% chlorantraniliprole technical.
Nov 2024: FMC Corporation; Licensing; Settled a patent dispute with Albaugh in the United States, under which Albaugh pays for a licence to FMC's chlorantraniliprole process patents.
Apr 2025: Shandong Youdao Chemical Co., Ltd.; Registration; Obtained US EPA registration for chlorantraniliprole technical.
Apr 2025: Natco Pharma Ltd.; Product Launch; Launched and began manufacturing cyantraniliprole 10.26% OD in India.
Nov 2025: Natco Pharma Ltd.; Legal; Delhi High Court refused FMC an interim injunction in a dispute involving a patent claiming a cyantraniliprole anthranilamide intermediate.
Feb 2026: FMC Corporation; Corporate Strategy; Initiated a review of strategic options, including a potential sale of the company.
May 2026: FMC Corporation; Divestment; Agreed to sell its India commercial business to Crystal Crop Protection for USD 252 Million, with continued diamide supply to the buyer.
May 2026: Zhejiang Zhongshan Chemical Industry Group; Expansion; Inner Mongolia Zhonggao Chemical received approval for a revised 12,000 tonne per year chlorantraniliprole project.
Jul 2026: Anhui Hengke Chemical Co., Ltd.; Expansion; Its CNY 310 Million project for pyrazole acid, anthranilamide and chlorantraniliprole technical was listed as an Anhui provincial key project, with trial production planned for August 2026.
Aug 2026: Lier Chemical Co., Ltd.; Expansion; Reported the chlorantraniliprole project at its Guang'an base as completed in its half-year 2026 report.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 105 companies operating in the Diamide Insecticide Intermediates Market market, including revenue, employee count, and market positioning where available.
Showing 105 of 105 companies
ADAMA is the world's leading pure-play off-patent crop protection company and the "value" arm of Syngenta Group. It does not discover new chemistry at the scale of the research majors; instead it takes active ingredients that have lost or are about to lose patent protection and re-engineers them through proprietary formulation platforms (Asorbital, Sesgama, T.O.V., Desidro, Ayalon) into mixtures that offer growers a measurable agronomic benefit at a lower price point than originator brands. It sells roughly USD 4 billion a year of herbicides, insecticides and fungicides, with a balanced footprint across Europe, North America, Latin America and Asia-Pacific, backed by back-integrated synthesis in Israel, China and Brazil. After a severe 2023–2024 downturn caused by channel destocking and Chinese active-ingredient overcapacity, the "Fight Forward" programme has restored margins and cash generation, although statutory earnings only turned positive in the first half of 2026 and leverage remains elevated. --- **What the company says.** In its results releases ADAMA describes itself as a global crop protection leader that supplies practical solutions to farmers for weeds, insects and disease, built on a diverse portfolio of existing active ingredients, formulation capability and proprietary formulation technology platforms. It states that it serves customers in dozens of countries with a direct presence in all of the top 20 agricultural markets (FY2025 PR, "About ADAMA"). Earlier boilerplate (FY2022 PR) referred to sales in more than 100 countries; the narrower current wording is consistent with the Fight Forward decision to concentrate on priority countries. **Independent characterisation.** ADAMA is an integrated post-patent agrochemical manufacturer and marketer. Its economics rest on four activities: 1. **Registration and regulatory work.** Value in off-patent crop protection is gated by product registrations country by country. ADAMA obtained 174 new registrations in 2025 and maintains a registration network covering more than 80 countries (2025 Annual Report, as summarised by Sohu Finance and Dongxing Securities). 2. **Formulation and mixture design.** The company manages more than 300 active ingredients centrally and about 1,300 end-use mixtures and formulations (Dongxing Securities note of 7 April 2026, citing the 2025 Annual Report). "Differentiated" products accounted for 45% of crop protection sales excluding active-ingredient sales in 2025. 3. **Manufacturing.** Synthesis of selected active ingredients and formulation at sites principally in Israel, China and Brazil (FY2025 PR). The company has moved away from producing certain basic chemicals in China and is explicitly shifting to a more flexible, asset-light supply network (H1 2026 PR). 4. **Go-to-market.** Sales are made mainly to distributors, retailers and cooperatives, with farmer-facing demand generation in priority markets. A smaller Consumer & Professional Solutions business in North America sells home, garden and professional pest-control products. **Revenue model.** Revenue is almost entirely product sales. There is no material subscription, licensing or service revenue disclosed; the December 2025 BASF agreement on Gilboa introduces a co-development and commercialisation arrangement whose financial terms are not publicly disclosed. In FY2025, Crop Protection contributed USD 3,730 million (92%) and Intermediates & Ingredients USD 321 million (8%) (FY2025 PR). **Value chain position.** ADAMA sits between upstream chemical intermediates suppliers (largely Chinese) and agricultural distribution. It is partially back-integrated into chlor-alkali and key intermediates, and buys a significant share of technical-grade active ingredients externally. This makes gross margin sensitive to the timing gap between falling procurement costs and falling selling prices, visible in the margin compression of 2023 and the recovery of 2024–2025. **Customers and end-markets.** End-users are growers of row crops (soybean, corn, cereals, cotton, rice, sugarcane), fruit and vegetables, and speciality crops. Non-agricultural customers include consumer and professional pest-control channels in North America and industrial buyers of intermediates, aroma chemicals and other non-ag products.
FMC Corporation is a Philadelphia-based, pure-play crop-protection company and one of the tier-one research-based agrochemical innovators, alongside Syngenta, Bayer, BASF and Corteva. It discovers, develops, manufactures and markets insecticides, herbicides, fungicides and "Plant Health" products (biologicals, crop nutrition, seed treatment) through distributors, retailers, cooperatives and, increasingly, direct-to-grower channels in Brazil. Its economic franchise was built on the diamide insecticides acquired from DuPont in 2017: Rynaxypyr® (~USD 0.8bn of FY2025 sales) and Cyazypyr® (~USD 0.4bn). Both have now lost core patent protection. FMC is therefore in a deep transition. FY2025 revenue fell to USD 3.47bn and the company booked a USD 2.24bn GAAP loss. It has cut the dividend 86%, fallen to junk credit status, and in 2026 raised capital through asset sales, a Corteva licence and a 20% equity stake sale to Tessenderlo Group. The equity case now rests on four new-mode-of-action active ingredients: Isoflex®, fluindapyr, Dodhylex™ and rimisoxafen. --- ### Company's own description (FY2025 10-K, paraphrased) FMC describes itself as a global agricultural sciences company that supplies farmers with innovative solutions to increase the productivity and resilience of their land, and states that it operates in a single business segment. It develops, markets and sells all three major classes of crop-protection chemicals (insecticides, herbicides and fungicides), together with biologicals, crop nutrition and seed-treatment products grouped as "Plant Health." The 10-K calls FMC a "tier-one leader" in agrochemicals, positioned through technology, geographic balance and crop diversity. For 2026 it sets four operational priorities: - strengthening the balance sheet; - improving competitiveness of the core portfolio; - managing the post-patent Rynaxypyr® transition; - supporting the growth of new active ingredients. ### Value-chain position FMC is a discovery-to-formulation innovator that relies heavily on outsourcing. It owns large-scale AI plants in: - Mobile, Alabama (USA) - Manati, Puerto Rico - Jinshan, China - Rønland, Denmark - Panoli, India It also sources "critical intermediates and finished products" largely from third parties in China and India (10-K FY2025 risk factors). Downstream, it sells through: - distributors, retailers and cooperatives in all four regions; - direct sales to large growers in Brazil, an expanding channel cited as a Q4 FY2026 growth driver; - alliance partners, including diamide partners on "cost-plus" contracts. ### Customer types and end-markets Customers are agricultural distributors and retailers, co-ops, large growers (Brazil), and other agrochemical companies that buy diamide AI under supply contracts. End-markets are row crops (soybean, corn, cotton, sugarcane, rice, cereals) and specialty crops (fruits, vegetables, tree nuts). Non-crop uses (pest control, turf) were largely exited with the sale of the Global Specialty Solutions business in November 2024. Demand is seasonal. Northern-hemisphere demand runs March–September, weighting Q1/Q2. Southern-hemisphere demand runs July–February, weighting Q3, Q4 and Q1 (10-K FY2025). ### Independent characterization FMC is a mid-sized research-based agrochemical company. It has a disproportionately concentrated franchise: the diamides were roughly 35% of FY2025 GAAP revenue (USD ~1.2bn of USD 3.47bn). The company is now caught between generic-driven price deflation on its legacy molecules and a still-sub-scale new-AI portfolio (USD ~200M in FY2025). It also faces an unusually leveraged balance sheet for a company of its size. Its strategy has shifted from "growth and returns" (2021–2023) to "survival and re-base" (2025–2026): - monetize IP through partners (Corteva); - shrink the manufacturing footprint (Project Foundation); - exit structurally unprofitable markets (India commercial); - recapitalize via a strategic minority investor (Tessenderlo).
DuPont de Nemours today is a focused, roughly USD 7 bn-revenue multi-industry company. It is no longer the diversified chemical conglomerate of its heritage. After a decade of portfolio surgery, the company consists of two segments: **Healthcare & Water Technologies (about 47% of FY2025 sales):** Tyvek® medical packaging and protective garments, specialty medical device components (Spectrum, Donatelle), and the FilmTec™ / Amberlite™ water purification franchise. **Diversified Industrials (about 53%):** Building envelope products (Tyvek® house wrap, Styrofoam™, Corian®) and engineered industrial technologies (Molykote®, Vespel®, Betaseal™/Betaforce™ adhesives, Cyrel® printing plates). The company earns a premium-specialty margin profile: operating EBITDA margin was 23.8% in FY2025, with guidance of about 24.5% for FY2026. Management targets 3–4% organic growth, 150–200 bps of margin expansion and 8–10% adjusted EPS CAGR through 2028, supported by a lightly levered BBB+/Baa1 balance sheet. The principal overhang is legacy PFAS liability, shared with Chemours, Corteva and Qnity under contractual arrangements. The principal opportunity is a cleaner, higher-growth healthcare/water mix and capital redeployment. --- **Company's own description (FY2025 10-K, Item 1).** DuPont describes itself as a leading provider of advanced solutions that improve everyday life across healthcare, water, construction and industrial markets. It emphasizes helping customers advance their technology pipelines, from clean water to medical packaging that enhances safety and performance. It names its competitive strengths as: - proprietary product and process technologies; - robust application-development pipelines; - well-known brands; - customer intimacy; - global manufacturing and local service capability. **Independent characterization.** DuPont is now best understood as a specialty engineered-materials and components company with four businesses of roughly comparable scale: **Business model and revenue model.** - Revenue is overwhelmingly product sales: materials, components, membranes, resins, garments and plates. Some engineered systems and modules are sold in Water. - There is no material subscription or licensing revenue. Trade secrets may be licensed occasionally (10-K, Intellectual Property). - The contract manufacturing and design services of Spectrum and Donatelle (medical devices) add a design-in / build-to-print services element, but are recognized as product revenue. - Seasonality: North American Building Technologies demand peaks in Q2–Q3. **Value-chain position.** DuPont sits mid-stream as a Tier-1/Tier-2 supplier. It converts purchased raw materials (polyolefins, specialty monomers, resins, silicones, polymers) into engineered materials, membranes and components. These are specified into customers' finished products: medical devices, sterile packaging, water plants, building envelopes, aircraft, vehicles and print packaging. **Customer types.** - Medical device OEMs and sterile packaging converters - Biopharma manufacturers - Industrial end users and EPC/OEM water-system integrators - Municipalities and desalination operators (via integrators) - Builders, contractors and distributors (e.g., Corian® distribution through Hallmark and Parksite) - Automotive and EV OEMs and Tier-1s - Aerospace OEMs - Printing and packaging converters Most products are sold through DuPont's own sales organization, with distributors used for some lines (10-K, Distribution). **End markets.** Healthcare (medical devices, packaging, biopharma, PPE), water (industrial, municipal/desalination, life sciences, microelectronics UPW), construction (residential, non-residential, repair/remodel) and industrial (aerospace, automotive/EV, printing and packaging, general industrial).
3 interactive charts drawn from the Diamide Insecticide Intermediates Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Diamide Insecticide Intermediates Market By Purity
Global Diamide Insecticide Intermediates Market By Downstream Product
Global Diamide Insecticide Intermediates Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
